US Stock MarketDetailed Quotes

Verrica Pharmaceuticals (VRCA)

Watchlist
  • 7.370
  • +0.220+3.08%
Close May 13 16:00 ET
  • 7.370
  • 0.0000.00%
Post 20:01 ET
126.61MMarket Cap-6.70P/E (TTM)

Verrica Pharmaceuticals (VRCA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
46.06%5.02M
370.22%35.58M
1,380.23%5.09M
905.39%14.34M
145.35%12.7M
-10.12%3.44M
47.66%7.57M
-82.70%344K
-161.06%-1.78M
2,744.51%5.18M
Operating revenue
46.06%5.02M
370.22%35.58M
1,380.23%5.09M
905.39%14.34M
145.35%12.7M
-10.12%3.44M
47.66%7.57M
-82.70%344K
-161.06%-1.78M
2,744.51%5.18M
Cost of revenue
103.43%889K
25.58%3.44M
124.16%1.4M
154.94%1.11M
-8.86%494K
-61.60%437K
267.29%2.74M
129.78%625K
61.11%435K
298.53%542K
Gross profit
37.71%4.13M
565.89%32.14M
1,413.52%3.69M
697.25%13.24M
163.39%12.21M
11.68%3M
10.23%4.83M
-116.38%-281K
-183.72%-2.22M
9,976.09%4.64M
Operating expense
24.41%13.85M
-37.63%44.08M
-3.70%10.64M
-37.21%11.61M
-46.08%10.7M
-47.71%11.13M
4.53%70.66M
-50.50%11.05M
-30.40%18.49M
70.13%19.84M
Selling and administrative expenses
12.90%9.99M
-40.12%35.22M
-17.83%8.12M
-41.53%9.4M
-46.42%8.85M
-45.85%8.85M
24.35%58.82M
-41.88%9.88M
-19.80%16.08M
178.29%16.52M
Research and development costs
69.00%3.86M
-25.21%8.86M
115.75%2.52M
-8.32%2.21M
-44.38%1.85M
-53.84%2.28M
-41.66%11.84M
-78.05%1.17M
-63.06%2.41M
-42.03%3.32M
Operating profit
-19.50%-9.72M
81.87%-11.94M
38.68%-6.95M
107.86%1.63M
109.93%1.51M
56.29%-8.13M
-4.13%-65.84M
45.01%-11.33M
13.43%-20.7M
-30.91%-15.21M
Net non-operating interest income expense
102.20%41K
14.78%-6.81M
48.27%-1.11M
10.21%-1.94M
3.65%-1.9M
-8.43%-1.87M
-554.26%-8M
-41.71%-2.14M
-158.08%-2.16M
-415.50%-1.98M
Non-operating interest income
-40.36%201K
-34.44%929K
0.00%205K
-28.05%159K
-41.98%228K
-43.65%337K
-48.28%1.42M
-74.12%205K
-73.11%221K
-37.22%393K
Non-operating interest expense
-92.74%160K
-17.74%7.74M
-44.06%1.31M
-11.87%2.09M
-10.01%2.13M
-5.00%2.2M
137.56%9.41M
1.91%2.35M
43.39%2.38M
--2.37M
Other net income (expense)
-103.15%-8K
131.51%866K
99.30%-19K
3,500.00%34K
12,040.00%597K
2,409.09%254K
-7.72%-2.75M
-9.15%-2.73M
98.00%-1K
-5K
Gain on sale of security
----
200.00%2.65M
--1.76M
--34K
--598K
--254K
---2.65M
----
----
----
Special income (charges)
----
-2,043.37%-1.78M
----
----
----
----
96.73%-83K
----
----
----
-Less:Other special charges
----
--1.53M
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
----
-196.39%-246K
----
----
----
----
96.73%-83K
----
----
----
Other non- operating income (expenses)
---8K
82.35%-3K
---2K
----
80.00%-1K
----
-21.43%-17K
--0
98.00%-1K
---5K
Income before tax
0.62%-9.68M
76.64%-17.89M
50.17%-8.07M
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
Income tax
Net income
0.62%-9.68M
76.64%-17.89M
50.17%-8.07M
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
Net income continuous Operations
0.62%-9.68M
76.64%-17.89M
50.17%-8.07M
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
Minority interest income
Net income attributable to the parent company
0.62%-9.68M
76.64%-17.89M
50.17%-8.07M
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.62%-9.68M
76.64%-17.89M
50.17%-8.07M
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
Basic earnings per share
56.31%-0.45
88.63%-1.68
76.25%-0.57
99.39%-0.03
100.54%0.02
76.59%-1.03
0.14%-14.78
55.56%-2.4
9.63%-4.88
-54.17%-3.7
Diluted earnings per share
56.31%-0.45
88.63%-1.68
76.25%-0.57
99.39%-0.03
100.54%0.02
76.59%-1.03
0.14%-14.78
55.56%-2.4
9.63%-4.88
-54.17%-3.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 46.06%5.02M370.22%35.58M1,380.23%5.09M905.39%14.34M145.35%12.7M-10.12%3.44M47.66%7.57M-82.70%344K-161.06%-1.78M2,744.51%5.18M
Operating revenue 46.06%5.02M370.22%35.58M1,380.23%5.09M905.39%14.34M145.35%12.7M-10.12%3.44M47.66%7.57M-82.70%344K-161.06%-1.78M2,744.51%5.18M
Cost of revenue 103.43%889K25.58%3.44M124.16%1.4M154.94%1.11M-8.86%494K-61.60%437K267.29%2.74M129.78%625K61.11%435K298.53%542K
Gross profit 37.71%4.13M565.89%32.14M1,413.52%3.69M697.25%13.24M163.39%12.21M11.68%3M10.23%4.83M-116.38%-281K-183.72%-2.22M9,976.09%4.64M
Operating expense 24.41%13.85M-37.63%44.08M-3.70%10.64M-37.21%11.61M-46.08%10.7M-47.71%11.13M4.53%70.66M-50.50%11.05M-30.40%18.49M70.13%19.84M
Selling and administrative expenses 12.90%9.99M-40.12%35.22M-17.83%8.12M-41.53%9.4M-46.42%8.85M-45.85%8.85M24.35%58.82M-41.88%9.88M-19.80%16.08M178.29%16.52M
Research and development costs 69.00%3.86M-25.21%8.86M115.75%2.52M-8.32%2.21M-44.38%1.85M-53.84%2.28M-41.66%11.84M-78.05%1.17M-63.06%2.41M-42.03%3.32M
Operating profit -19.50%-9.72M81.87%-11.94M38.68%-6.95M107.86%1.63M109.93%1.51M56.29%-8.13M-4.13%-65.84M45.01%-11.33M13.43%-20.7M-30.91%-15.21M
Net non-operating interest income expense 102.20%41K14.78%-6.81M48.27%-1.11M10.21%-1.94M3.65%-1.9M-8.43%-1.87M-554.26%-8M-41.71%-2.14M-158.08%-2.16M-415.50%-1.98M
Non-operating interest income -40.36%201K-34.44%929K0.00%205K-28.05%159K-41.98%228K-43.65%337K-48.28%1.42M-74.12%205K-73.11%221K-37.22%393K
Non-operating interest expense -92.74%160K-17.74%7.74M-44.06%1.31M-11.87%2.09M-10.01%2.13M-5.00%2.2M137.56%9.41M1.91%2.35M43.39%2.38M--2.37M
Other net income (expense) -103.15%-8K131.51%866K99.30%-19K3,500.00%34K12,040.00%597K2,409.09%254K-7.72%-2.75M-9.15%-2.73M98.00%-1K-5K
Gain on sale of security ----200.00%2.65M--1.76M--34K--598K--254K---2.65M------------
Special income (charges) -----2,043.37%-1.78M----------------96.73%-83K------------
-Less:Other special charges ------1.53M--------------------------------
-Gain on sale of property,plant,equipment -----196.39%-246K----------------96.73%-83K------------
Other non- operating income (expenses) ---8K82.35%-3K---2K----80.00%-1K-----21.43%-17K--098.00%-1K---5K
Income before tax 0.62%-9.68M76.64%-17.89M50.17%-8.07M98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M
Income tax
Net income 0.62%-9.68M76.64%-17.89M50.17%-8.07M98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M
Net income continuous Operations 0.62%-9.68M76.64%-17.89M50.17%-8.07M98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M
Minority interest income
Net income attributable to the parent company 0.62%-9.68M76.64%-17.89M50.17%-8.07M98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.62%-9.68M76.64%-17.89M50.17%-8.07M98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M
Basic earnings per share 56.31%-0.4588.63%-1.6876.25%-0.5799.39%-0.03100.54%0.0276.59%-1.030.14%-14.7855.56%-2.49.63%-4.88-54.17%-3.7
Diluted earnings per share 56.31%-0.4588.63%-1.6876.25%-0.5799.39%-0.03100.54%0.0276.59%-1.030.14%-14.7855.56%-2.49.63%-4.88-54.17%-3.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More